|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/47 | |
| G01N 33/68 |
| (11) | Number of the document | 2459212 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10806936.0 |
| Date of filing the European patent application | 2010-07-28 | |
| (97) | Date of publication of the European application | 2012-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/043586 |
| Date | 2010-07-28 |
| (87) | Number | WO 2011/017177 |
| Date | 2011-02-10 |
| (30) | Number | Date | Country code |
| 303044 P | 2010-02-10 | US | |
| 317513 P | 2010-03-25 | US | |
| 333372 P | 2010-05-11 | US | |
| 229195 P | 2009-07-28 | US | |
| 359338 P | 2010-06-28 | US |
| (72) |
DANIEL, Peter, F., US
HEARTLEIN, Michael, W., US
|
| (73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington MA 02421,
US
|
| (54) | COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE |
| COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE |